Sangro B, Melero I, Yau T, et al. Nivolumab in Sorafenib-Naive and -Experienced Patients With Advanced Hepatocellular Carcinoma (HCC): Survival, Hepatic Safety, and Biomarker Assessments in CheckMate 040. AAASLD 2017, Presidential Poster of Distinction 141.
Diepe invasie helemaal loslaten als risicofactor bij risicostratificatie T1-poliepen?
jan 2023 | Endoscopie, Maag-darm-leveroncologie